Suppr超能文献

秋水仙碱用于儿童复发性心包炎

Colchicine for recurrent pericarditis in children.

作者信息

Yazigi A, Abou-Charaf L C

机构信息

Department of Paediatrics, St. George Hospital, Beirut, Lebanon.

出版信息

Acta Paediatr. 1998 May;87(5):603-4. doi: 10.1080/08035259850158399.

Abstract

The incidence of recurrence of acute pericarditis in children varies from 15% to 30% and is accompanied by a high morbidity. Various treatment modalities have been used with variable success rates and side effects. La Serna et al. (Lancet 1987; 26: 1517) were the first to treat adults with recurrent pericarditis with colchicine, and were followed by other authors. To our knowledge no studies in children have been reported. In this paper, we present three children who suffered from viral or idiopathic recurrent pericarditis, despite multiple courses of non-steroidal anti-inflammatory drugs (NSAIDs) and/or corticosteroids. They responded remarkably well to colchicine, which was administered for 6 months with no adverse reactions. They continue to do well 18, 11 and 12 months after cessation of treatment, respectively.

摘要

儿童急性心包炎的复发率在15%至30%之间,且发病率较高。人们采用了各种治疗方式,成功率和副作用各不相同。拉萨尔纳等人(《柳叶刀》1987年;26: 1517)率先用秋水仙碱治疗复发性心包炎的成人患者,随后其他作者也进行了相关治疗。据我们所知,尚无关于儿童的研究报道。在本文中,我们介绍了三名患有病毒性或特发性复发性心包炎的儿童,他们尽管接受了多疗程的非甾体抗炎药(NSAIDs)和/或皮质类固醇治疗。他们对秋水仙碱反应良好,服用6个月且无不良反应。分别在停药后18、11和12个月,他们仍状况良好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验